Portfolio Holdings Detail for ISIN IE0002EKOXU6
| Stock Name / Fund | iShares Russell 1000 Value UCITS ETF |
| Issuer | Blackrock |
| Entity holding fund | iShares VII Public Limited Company |
| Entity Type | Umbrella investment company with variable capital and having segregated liability between its funds |
| Entity LEI | 549300Q7FFITMZ2PFZ28 |
| ETF Ticker | R1VL(USD) LSE |
| ETF Ticker | R1VL.AS(USD) Euronext Amsterdam |
| ETF Ticker | R1VL.L(GBP) LSE |
Holdings detail for INSM
| Stock Name | Insmed Inc |
| Ticker | INSM(USD) NASDAQ |
| TYPE | Common Stock |
| Country | USA |
| ISIN | US4576693075 |
| LEI | 529900Q55QAG41CCAC11 |
Show aggregate INSM holdings
News associated with INSM
- Analysts Set Insmed, Inc. (NASDAQ:INSM) Price Target at $139.86
- Insmed, Inc. (NASDAQ:INSM – Get Free Report) has been assigned an average rating of “Moderate Buy” from the seventeen brokerages that are covering the firm, MarketBeat.com reports. One research analyst has rated the stock with a hold recommendation and sixteen have assigned a buy recommendation to the company. The average 1-year target price among brokerages […] - 2025-09-17 02:58:45
- Insmed (NASDAQ:INSM) Reaches New 12-Month High on Analyst Upgrade
- Shares of Insmed, Inc. (NASDAQ:INSM – Get Free Report) hit a new 52-week high on Monday after Guggenheim raised their price target on the stock from $125.00 to $172.00. Guggenheim currently has a buy rating on the stock. Insmed traded as high as $146.91 and last traded at $145.86, with a volume of 288114 shares […] - 2025-09-10 02:26:50
- Top Analyst Reports for Microsoft, Amazon.com & Philip Morris
- Microsoft, Amazon.com and Philip Morris headline fresh analyst reports highlighting AI, cloud, and smoke-free growth momentum. - 2025-09-05 18:11:00
- Notable ETF Outflow Detected - XBI, ALNY, HALO, INSM
- Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an approximate $119.6 million dollar outflow -- that's a 2.2% decrease week over week - 2025-08-28 11:56:11
- Insmed (NASDAQ:INSM) Earns Outperform Rating from Analysts at William Blair
- Stock analysts at William Blair initiated coverage on shares of Insmed (NASDAQ:INSM – Get Free Report) in a research note issued on Wednesday, MarketBeat Ratings reports. The firm set an “outperform” rating on the biopharmaceutical company’s stock. Other research analysts also recently issued reports about the stock. Truist Financial upped their target price on shares […] - 2025-08-22 02:54:45
- IMCB's Underlying Holdings Could Mean 12% Gain Potential
- Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-08-18 09:44:41
- The Goldman Sachs Group Forecasts Strong Price Appreciation for Insmed (NASDAQ:INSM) Stock
- Insmed (NASDAQ:INSM – Get Free Report) had its target price increased by equities researchers at The Goldman Sachs Group from $114.00 to $142.00 in a research note issued to investors on Wednesday,Benzinga reports. The firm currently has a “buy” rating on the biopharmaceutical company’s stock. The Goldman Sachs Group’s price target indicates a potential upside […] - 2025-08-15 07:10:57
- INSM Crosses Above Average Analyst Target
- In recent trading, shares of Insmed Inc (Symbol: INSM) have crossed above the average analyst 12-month target price of $119.12, changing hands for $122.00/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuati - 2025-08-13 10:41:52
- Insmed (NASDAQ:INSM) Reaches New 1-Year High Following Analyst Upgrade
- Insmed, Inc. (NASDAQ:INSM – Get Free Report)’s share price hit a new 52-week high during mid-day trading on Monday after Wells Fargo & Company raised their price target on the stock from $119.00 to $130.00. Wells Fargo & Company currently has an overweight rating on the stock. Insmed traded as high as $113.41 and last […] - 2025-08-13 02:23:00
- XBI, ALNY, INSM, INCY: Large Outflows Detected at ETF
- Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an approximate $202.3 million dollar outflow -- that's a 4.3% decrease week over week - 2025-08-12 11:55:54
- Insmed, Inc. (NASDAQ:INSM) Shares Purchased by Charles Schwab Investment Management Inc.
- Charles Schwab Investment Management Inc. raised its stake in shares of Insmed, Inc. (NASDAQ:INSM – Free Report) by 3.6% during the 1st quarter, Holdings Channel reports. The institutional investor owned 1,602,655 shares of the biopharmaceutical company’s stock after buying an additional 56,048 shares during the period. Charles Schwab Investment Management Inc.’s holdings in Insmed were […] - 2025-08-12 05:59:02
- Mackenzie Financial Corp Acquires 2,220 Shares of Insmed, Inc. (NASDAQ:INSM)
- Mackenzie Financial Corp lifted its holdings in Insmed, Inc. (NASDAQ:INSM – Free Report) by 20.4% in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 13,103 shares of the biopharmaceutical company’s stock after buying an additional 2,220 shares during the quarter. Mackenzie Financial Corp’s holdings in […] - 2025-08-06 05:07:44
- Insmed, Inc. (NASDAQ:INSM) Shares Acquired by Cwm LLC
- Cwm LLC grew its holdings in Insmed, Inc. (NASDAQ:INSM – Free Report) by 24.5% in the 1st quarter, HoldingsChannel.com reports. The fund owned 2,052 shares of the biopharmaceutical company’s stock after buying an additional 404 shares during the quarter. Cwm LLC’s holdings in Insmed were worth $157,000 as of its most recent SEC filing. Several […] - 2025-07-29 04:28:55
- Allianz Asset Management GmbH Has $5.74 Million Holdings in Insmed, Inc. (NASDAQ:INSM)
- Allianz Asset Management GmbH raised its stake in shares of Insmed, Inc. (NASDAQ:INSM – Free Report) by 4.9% in the first quarter, Holdings Channel.com reports. The firm owned 75,284 shares of the biopharmaceutical company’s stock after buying an additional 3,534 shares during the period. Allianz Asset Management GmbH’s holdings in Insmed were worth $5,743,000 as […] - 2025-07-28 05:46:50
- Congress Trade: Representative Josh Gottheimer Just Disclosed New Stock Trades
- Representative Josh Gottheimer just filed new stock trades, which we received from a STOCK Act disclosure. You can see the full list of trades on Quiver Quantitative's congress trading dashboard, and track the portfolios of Representative Josh Gottheimer and other politicians. - 2025-07-17 10:12:46
- Insmed, Inc. (NASDAQ:INSM) Shares Bought by Xponance Inc.
- Xponance Inc. boosted its stake in shares of Insmed, Inc. (NASDAQ:INSM – Free Report) by 5.3% during the first quarter, according to its most recent Form 13F filing with the SEC. The fund owned 13,359 shares of the biopharmaceutical company’s stock after buying an additional 670 shares during the period. Xponance Inc.’s holdings in Insmed […] - 2025-07-17 06:35:03
- Envestnet Asset Management Inc. Grows Holdings in Insmed, Inc. (NASDAQ:INSM)
- Envestnet Asset Management Inc. raised its position in Insmed, Inc. (NASDAQ:INSM – Free Report) by 26.9% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 325,307 shares of the biopharmaceutical company’s stock after purchasing an additional 68,949 shares during the quarter. Envestnet Asset Management […] - 2025-07-16 07:23:19
- Sara Bonstein Sells 57,764 Shares of Insmed, Inc. (NASDAQ:INSM) Stock
- Insmed, Inc. (NASDAQ:INSM – Get Free Report) CFO Sara Bonstein sold 57,764 shares of the company’s stock in a transaction on Monday, July 7th. The shares were sold at an average price of $95.86, for a total value of $5,537,257.04. Following the completion of the sale, the chief financial officer owned 84,017 shares in the […] - 2025-07-11 05:13:00
- Teacher Retirement System of Texas Sells 2,654 Shares of Insmed, Inc. (NASDAQ:INSM)
- Teacher Retirement System of Texas lessened its holdings in shares of Insmed, Inc. (NASDAQ:INSM – Free Report) by 5.5% during the 1st quarter, Holdings Channel.com reports. The firm owned 45,683 shares of the biopharmaceutical company’s stock after selling 2,654 shares during the period. Teacher Retirement System of Texas’ holdings in Insmed were worth $3,485,000 at […] - 2025-07-09 05:48:57
- Brokerages Set Insmed, Inc. (NASDAQ:INSM) Target Price at $106.80
- Shares of Insmed, Inc. (NASDAQ:INSM – Get Free Report) have earned an average rating of “Buy” from the seventeen brokerages that are presently covering the stock, MarketBeat Ratings reports. Seventeen equities research analysts have rated the stock with a buy recommendation. The average 12-month price target among brokers that have updated their coverage on the […] - 2025-07-04 02:40:47
- Insmed, Inc. (NASDAQ:INSM) CFO Sara Bonstein Sells 57,765 Shares
- Insmed, Inc. (NASDAQ:INSM – Get Free Report) CFO Sara Bonstein sold 57,765 shares of the stock in a transaction on Monday, June 23rd. The shares were sold at an average price of $101.78, for a total value of $5,879,321.70. Following the completion of the sale, the chief financial officer now owns 93,536 shares in the […] - 2025-06-27 05:06:55
- Avior Wealth Management LLC Raises Holdings in Insmed, Inc. (NASDAQ:INSM)
- Avior Wealth Management LLC lifted its holdings in shares of Insmed, Inc. (NASDAQ:INSM – Free Report) by 82.2% during the first quarter, according to its most recent disclosure with the SEC. The fund owned 4,151 shares of the biopharmaceutical company’s stock after acquiring an additional 1,873 shares during the period. Avior Wealth Management LLC’s holdings […] - 2025-06-23 05:12:58
- Is Insmed Stock Overvalued at $98?
- Insmed Inc (NASDAQ: INSM) was nothing short of a juggernaut last month, skyrocketing 45%, while the S&P500 index gained 3% during the same period. What’s fueling the fire? Insmed announced that its Phase IIb trial for treprostinil palmitil inhalation powder (TPIP) in pulmonar - 2025-06-17 03:35:22
- Notable ETF Outflow Detected - IWO, SFM, INSM, FTAI
- Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Russell 2000 Growth ETF (Symbol: IWO) where we have detected an approximate $123.7 million dollar outflow -- that's a 1.1% decrease week ove - 2025-06-16 11:49:52
- Insmed Incorporated (NASDAQ:INSM) CFO Sells $5,148,105.92 in Stock
- Insmed Incorporated (NASDAQ:INSM – Get Free Report) CFO Sara Bonstein sold 57,766 shares of the company’s stock in a transaction on Tuesday, June 10th. The stock was sold at an average price of $89.12, for a total transaction of $5,148,105.92. Following the sale, the chief financial officer now directly owns 103,412 shares in the company, […] - 2025-06-16 05:18:57
- Park Avenue Securities LLC Has $842,000 Holdings in Insmed Incorporated (NASDAQ:INSM)
- Park Avenue Securities LLC boosted its position in shares of Insmed Incorporated (NASDAQ:INSM – Free Report) by 38.7% during the 1st quarter, Holdings Channel reports. The institutional investor owned 11,036 shares of the biopharmaceutical company’s stock after purchasing an additional 3,081 shares during the quarter. Park Avenue Securities LLC’s holdings in Insmed were worth $842,000 […] - 2025-06-13 05:18:50
- Morgan Stanley Increases Insmed (NASDAQ:INSM) Price Target to $102.00
- Insmed (NASDAQ:INSM – Get Free Report) had its price objective lifted by stock analysts at Morgan Stanley from $90.00 to $102.00 in a report released on Wednesday,Benzinga reports. The firm currently has an “overweight” rating on the biopharmaceutical company’s stock. Morgan Stanley’s target price suggests a potential upside of 5.28% from the stock’s previous close. […] - 2025-06-13 04:40:52
- Insmed (NASDAQ:INSM) Stock Price Expected to Rise, Royal Bank of Canada Analyst Says
- Insmed (NASDAQ:INSM – Get Free Report) had its target price raised by research analysts at Royal Bank of Canada from $99.00 to $106.00 in a report issued on Wednesday,Benzinga reports. The brokerage presently has an “outperform” rating on the biopharmaceutical company’s stock. Royal Bank of Canada’s price target would suggest a potential upside of 9.41% […] - 2025-06-13 04:40:51
- Insmed (NASDAQ:INSM) Stock Price Expected to Rise, Mizuho Analyst Says
- Insmed (NASDAQ:INSM – Get Free Report) had its price objective lifted by equities research analysts at Mizuho from $96.00 to $110.00 in a report issued on Wednesday,Benzinga reports. The firm presently has an “outperform” rating on the biopharmaceutical company’s stock. Mizuho’s price target points to a potential upside of 13.54% from the company’s current price. […] - 2025-06-13 04:40:49
- Insmed (NASDAQ:INSM) Shares Up 4.5% Following Analyst Upgrade
- Insmed Incorporated (NASDAQ:INSM – Get Free Report)’s stock price traded up 4.5% during trading on Wednesday after The Goldman Sachs Group raised their price target on the stock from $100.00 to $112.00. The Goldman Sachs Group currently has a buy rating on the stock. Insmed traded as high as $93.82 and last traded at $95.02. […] - 2025-06-13 02:17:01
iShares Russell 1000 Value UCITS ETF INSM holdings
| Date | Number of INSM Shares Held | Base Market Value of INSM Shares | Local Market Value of INSM Shares | Change in INSM Shares Held | Change in INSM Base Value | Current Price per INSM Share Held | Previous Price per INSM Share Held |
|---|
| 2025-12-02 (Tuesday) | 100 | USD 20,660 | USD 20,660 | | | | |
| 2025-12-01 (Monday) | 99 | USD 20,930 | USD 20,930 | 0 | USD 361 | USD 211.414 | USD 207.768 |
| 2025-11-28 (Friday) | 99 | USD 20,569 | USD 20,569 | 0 | USD 323 | USD 207.768 | USD 204.505 |
| 2025-11-27 (Thursday) | 99 | USD 20,246 | USD 20,246 | 0 | USD 0 | USD 204.505 | USD 204.505 |
| 2025-11-26 (Wednesday) | 99 | USD 20,246 | USD 20,246 | 0 | USD -447 | USD 204.505 | USD 209.02 |
| 2025-11-25 (Tuesday) | 99 | USD 20,693 | USD 20,693 | 1 | USD 414 | USD 209.02 | USD 206.929 |
| 2025-11-24 (Monday) | 98 | USD 20,279 | USD 20,279 | 0 | USD 801 | USD 206.929 | USD 198.755 |
| 2025-11-21 (Friday) | 98 | USD 19,478 | USD 19,478 | 0 | USD -87 | USD 198.755 | USD 199.643 |
| 2025-11-20 (Thursday) | 98 | USD 19,565 | USD 19,565 | 0 | USD -384 | USD 199.643 | USD 203.561 |
| 2025-11-19 (Wednesday) | 98 | USD 19,949 | USD 19,949 | 1 | USD 392 | USD 203.561 | USD 201.619 |
| 2025-11-18 (Tuesday) | 97 | USD 19,557 | USD 19,557 | 4 | USD 1,199 | USD 201.619 | USD 197.398 |
| 2025-11-17 (Monday) | 93 | USD 18,358 | USD 18,358 | 0 | USD 389 | USD 197.398 | USD 193.215 |
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdingsShare Trades of INSM by Blackrock for IE0002EKOXU6
Show aggregate share trades of INSM| Date | Action | Quantity | Market High | Market Low | Likely Trade Price | Likely Trade Value (Profit/Loss) | Average Price previous trades |
|---|
| 2025-11-25 | BUY | 1 | 209.770 | 205.230 | 205.684 | USD 206 | 176.96 |
| 2025-11-19 | BUY | 1 | 205.110 | 200.190 | 200.682 | USD 201 | 173.70 |
| 2025-11-18 | BUY | 4 | 203.650 | 195.510 | 196.324 | USD 785 | 172.77 |
| 2025-11-05 | BUY | 1 | 189.305 | 182.090 | 182.811 | USD 183 | 164.73 |
| 2025-10-31 | BUY | 1 | 197.080 | 187.020 | 188.026 | USD 188 | 161.15 |
| 2025-10-22 | BUY | 1 | 160.400 | 166.620 | 165.998 | USD 166 | 157.27 |
| 2025-10-21 | SELL | -96 | 165.310 | 168.090 | 167.812 | USD -16,110 | 156.47 Loss of -1,089 on sale |
| 2025-10-14 | BUY | 9 | 161.380 | 164.340 | 164.044 | USD 1,476 | 148.58 |
| 2025-09-30 | BUY | 6 | 144.010 | 145.410 | 145.270 | USD 872 | 141.65 |
Market high and low price is on the date. * (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection
The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close
Shorting History of INSM
| Date | Shorted Volume | Short Exempt Volume | Total Shares Traded | % Shorted |
|---|
| 2025-09-19 | 172,531 | 1,415 | 480,687 | 35.9% |
| 2025-09-18 | 192,419 | 1,396 | 488,532 | 39.4% |
| 2025-09-17 | 258,254 | 358 | 657,586 | 39.3% |
| 2025-09-16 | 234,877 | 118 | 631,379 | 37.2% |
| 2025-09-15 | 281,798 | 0 | 849,087 | 33.2% |
| 2025-09-12 | 276,876 | 0 | 792,549 | 34.9% |
| 2025-09-11 | 232,789 | 1,547 | 706,713 | 32.9% |
| 2025-09-10 | 298,194 | 739 | 767,290 | 38.9% |
| 2025-09-09 | 285,006 | 1 | 607,090 | 46.9% |
| 2025-09-08 | 226,229 | 224 | 654,288 | 34.6% |
| 2025-09-05 | 325,826 | 28 | 1,044,438 | 31.2% |
| 2025-09-04 | 248,903 | 665 | 733,063 | 34.0% |
| 2025-09-03 | 350,854 | 0 | 1,100,919 | 31.9% |
| 2025-09-02 | 978,520 | 3,528 | 2,123,858 | 46.1% |
| 2025-08-29 | 391,481 | 15 | 838,637 | 46.7% |
| 2025-08-28 | 307,994 | 19,763 | 681,033 | 45.2% |
| 2025-08-27 | 359,423 | 0 | 988,381 | 36.4% |
| 2025-08-26 | 309,084 | 9 | 862,404 | 35.8% |
| 2025-08-25 | 328,526 | 86 | 915,125 | 35.9% |
| 2025-08-22 | 499,368 | 0 | 1,021,146 | 48.9% |
| 2025-08-21 | 473,469 | 1,317 | 988,731 | 47.9% |
| 2025-08-20 | 436,053 | 3,929 | 931,883 | 46.8% |
| 2025-08-19 | 428,166 | 0 | 1,016,557 | 42.1% |
| 2025-08-18 | 562,718 | 1,268 | 1,332,877 | 42.2% |
| 2025-08-15 | 736,274 | 30 | 1,803,556 | 40.8% |
| 2025-08-14 | 1,023,934 | 320 | 2,229,622 | 45.9% |
| 2025-08-13 | 722,475 | 1 | 2,238,834 | 32.3% |
| 2025-08-12 | 1,753,666 | 701 | 3,484,210 | 50.3% |
| 2025-08-11 | 511,651 | 0 | 1,434,176 | 35.7% |
| 2025-08-08 | 360,306 | 0 | 1,213,665 | 29.7% |
| 2025-08-07 | 435,145 | 186 | 1,629,363 | 26.7% |
| 2025-08-06 | 541,497 | 1,814 | 1,567,245 | 34.6% |
| 2025-08-05 | 557,375 | 3,053 | 1,406,789 | 39.6% |
| 2025-08-04 | 510,869 | 48 | 1,127,744 | 45.3% |
| 2025-08-01 | 385,708 | 1,135 | 1,044,895 | 36.9% |
| 2025-07-31 | 570,588 | 2,598 | 1,011,306 | 56.4% |
| 2025-07-30 | 777,296 | 1,400 | 1,553,457 | 50.0% |
| 2025-07-29 | 245,874 | 242 | 687,941 | 35.7% |
| 2025-07-28 | 330,814 | 146 | 938,038 | 35.3% |
| 2025-07-25 | 243,537 | 471 | 722,557 | 33.7% |
| 2025-07-24 | 171,398 | 18 | 713,656 | 24.0% |
| 2025-07-23 | 236,916 | 636 | 800,818 | 29.6% |
| 2025-07-22 | 228,382 | 0 | 552,067 | 41.4% |
| 2025-07-21 | 252,530 | 0 | 764,289 | 33.0% |
| 2025-07-18 | 244,497 | 1,210 | 505,608 | 48.4% |
The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.
Back to Listing
Note: All information is provided as is without warranty and should be used for indicative purposes only.
You should independently check data before making any investment decision.
This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.
Copyright Market Footprint Ltd. Privacy Policy